Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 1 | 904 | 4q35.1 | TLR3 | toll like receptor 3 | |
Mouse | 1 | 905 | 8 B1.1 | Tlr3 | toll-like receptor 3 | |
Rat | - | - | 16q11 | Tlr3 | toll-like receptor 3 |
Previous and Unofficial Names |
toll-like receptor 3 | CD283 | IIAE2 |
Database Links | |
Alphafold | O15455 (Hs), Q99MB1 (Mm) |
CATH/Gene3D | 3.80.10.10, 3.40.50.10140 |
ChEMBL Target | CHEMBL1075113 (Hs), CHEMBL2146340 (Mm) |
Ensembl Gene | ENSG00000164342 (Hs), ENSMUSG00000031639 (Mm), ENSRNOG00000021726 (Rn) |
Entrez Gene | 7098 (Hs), 142980 (Mm), 364594 (Rn) |
Human Protein Atlas | ENSG00000164342 (Hs) |
KEGG Gene | hsa:7098 (Hs), mmu:142980 (Mm), rno:364594 (Rn) |
OMIM | 603029 (Hs) |
Pharos | O15455 (Hs) |
UniProtKB | O15455 (Hs), Q99MB1 (Mm) |
Wikipedia | TLR3 (Hs) |
Activator Comments | ||
Poly(I:C) activation of TLR3 is assessed by its ability to induce cytokine production or activation of NF-κB and mitogen-activated protein (MAP) kinases [1]. |
Immunopharmacology Comments |
TLR3 is an endosomal anti-viral receptor [2], with potent pro-inflammatory actions (e.g. induction of Type I IFN and pro-inflammatory cytokines, including IL-6, TNF, IL-17, IL-21, IP-10 and RANTES). Innate Pharma are developing IPH33 as an anti-TLR3 anti-inflammatory biologic, which acts upstream relative to current therapies such as anti-TNF and anti-IL-6 mAbs and small molecule JAK inhibitors. |
Immuno Process Associations | ||
|
||
|
||
|
||
|
||
|
||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature, 413 (6857): 732-8. [PMID:11607032]
2. Uematsu S, Akira S. (2008) Toll-Like receptors (TLRs) and their ligands. Handb Exp Pharmacol, (183): 1-20. [PMID:18071652]